New way to find “aged” cells marks fresh approach for research into ageing
Electric fields help differentiate healthy and “senescent” cells
2025-06-21
(Press-News.org)
Tokyo, Japan – Researchers from Tokyo Metropolitan University have created a new way of telling “aged” human cells apart from younger ones using electric fields. While key markers have been found for these “senescent” cells, current methods require biochemical “labels” which are difficult to apply and affect the cells themselves, making them difficult to study. The new method is label-free and less damaging. The team aims to diversify the method, extending it to other cell types.
Ageing starts at the cellular level. As we get older, aged or “senescent” cells accumulate in our body. Not only have these cells lost much of their original function, but they continue to emit compounds which trigger inflammation. There is a growing body of evidence for how they play a part in ageing-related conditions like arterial hardening, Alzheimer’s disease, and type 2 diabetes.
To understand and treat such ailments, scientists need to come to grips with how senescent cells affect our physiology. Naturally, this starts with identifying which of our cells are senescent, and which are not. Unfortunately, existing methods rely on selective “labeling,” e.g. the attachment of a fluorescent molecule to specific compounds known to be present in aged cells. Not only is this time-consuming and complex, but the process itself can change the properties of the very thing scientists want to study.
To get around this issue, a team led by Assistant Professor Ippei Yagi from Tokyo Metropolitan University has come up with an entirely different approach to identifying senescent cells. Instead of chemical labels, they put cells under an alternating electric field. This causes a slight rearrangement of charge, where one end of the cell is more positively charged than the other. When the electric field is not uniform over space, the cell migrates; in the case of an alternating field, the cell wanders backwards and forwards between the electrodes. As the frequency of the field is changed, the motion of the cell changes significantly at a value known as the cutoff frequency. The method, known as frequency-modulated dielectrophoresis (FM-DEP), aims to characterize cell type by measuring this value.
The team focused their efforts on human dermal fibroblasts, an important part of connective tissue in the skin. When they tested senescent cells against younger ones, they found that there was a marked difference in their cutoff frequencies. These changes come about from changes in the fatty (lipid) molecules which make up the membrane of the cells. Importantly, FM-DEP is rapid, easy to apply, and label-free.
The new method is not only a convenient tool for research into ageing, but may see application to regenerative medicine, and drug screening. The team hope to apply FM-DEP to other cell types as well, as a versatile new approach to cell identification.
This work was supported by JSPS KAKENHI Grant Numbers JP23K28453 and JP23KK0260.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-06-20
(Helsinki, Finland, Saturday, 21 June 2025) A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new study presented today at the European Academy of Neurology (EAN) Congress 2025.1
Researchers at the Headache Centre of the University of Naples “Federico II” gave the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide to 26 adults with obesity and chronic migraine (defined as ≥15 headache days per month). Patients reported an average of 11 fewer headache days per month, while disability scores on the Migraine Disability Assessment Test ...
2025-06-20
(Helsinki, Finland, Saturday, 21 June 2025) New research, presented today at the European Academy of Neurology (EAN) Congress 2025, has uncovered a powerful link between nighttime heart rhythm and future health conditions, even in people with no obvious sleep problems.1
The study, which was conducted at the Department of Neurology, Inselspital, the University Hospital of Bern, analysed 4,170 individuals over an observation period of 13,217 person-years, found that heart rate variability (HRV) during sleep can serve ...
2025-06-20
Scientists and engineers study the atomic interactions that happen on the surface of materials to develop more energy efficient batteries, capacitors, and other devices. But accurately simulating these fundamental interactions requires immense computing power to fully capture the geometrical and chemical intricacies involved, and current methods are just scratching the surface.
“Currently it’s prohibitive and there’s no supercomputer in the world that can do an analysis like that,” says Siddharth Deshpande, an assistant professor in the University of Rochester’s Department of Chemical Engineering. “We need clever ways to manage ...
2025-06-20
June 18, 2025 - The highly anticipated 2024 Journal Citation Reports (JCR) were officially released today, marking a significant achievement for Current Molecular Pharmacology (CMP). The journal's 2024 Impact Factor has increased to 2.9, with a five-year Impact Factor of 3.1, successfully advancing to the Q2 zone in the PHARMACOLOGY & PHARMACY category. This accomplishment signifies a notable enhancement in CMP's academic influence and recognition.
CMP is dedicated to publishing the latest advancements ...
2025-06-20
For many patients, radioactive iodine treatment after thyroid cancer surgery means side effects like nausea and time in hospital isolated from loved ones. But new clinical trial results from researchers at UCL mean hundreds of thousands of patients worldwide could now safely be spared this treatment.
Globally, around 820,000 people are diagnosed with thyroid cancer each year. Compared to most cancers, it affects a high proportion of younger people who are more likely to be parents to young children. It is also three times more common in women than men.
The Iodine or Not (IoN) clinical ...
2025-06-20
NEW YORK, NY (June 20, 2025)—A new laboratory method developed by researchers at Columbia University Vagelos College of Physicians and Surgeons may now help physicians more quickly diagnose patients with suspected genetic disorders of the immune system, many who have been trapped in diagnostic limbo for years.
The researchers, who published their findings June 20 in Cell, applied the method to one rare inborn error of immunity called activated-PI3Kδ syndrome (APDS) and found dozens of additional genetic variations that could cause the syndrome.
“Our findings give physicians a resource that can help them rapidly diagnose and treat ...
2025-06-20
(MEMPHIS, Tenn. – June 20, 2025) The relationship between genetic variants and the risk of late-onset cardiomyopathy remains poorly understood in survivors of childhood cancer despite being otherwise well established. Scientists from St. Jude Children’s Research Hospital have helped address this gap, assessing whether variant trends seen in the general population also apply to late-onset cardiomyopathy in five-year survivors of childhood cancer. The work revealed that, as in the general population, common variants in TTNand BAG3 are associated with reduced late-onset cardiomyopathy ...
2025-06-20
The Simons Foundation Autism Research Initiative (SFARI) has released phenotypic and genetic data from the Autism Inpatient Collection (AIC), a cohort of more than 1,500 youth participants ages 4 to 20 years old who were hospitalized in one of six child psychiatry units in the United States. The AIC, supported by SFARI and the Nancy Lurie Marks Family Foundation, aimed to engage these individuals, many of whom meet recently proposed criteria for ‘profound autism’ (autism characterized by intellectual disability or minimal language that requires high ...
2025-06-20
Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute today report the identification of a novel combination therapy approach to treat pediatric acute myeloid leukemia (AML). Standard treatment is often ineffective against AML, a cancer that commonly relapses with poor prognosis, particularly when the disease is fueled by fusion proteins involving NUP98. The researchers documented how these fusions drive disease, discovering a protein complex required to express cancer-promoting genes. When they targeted the complex alone or in combination with another anticancer drug, survival significantly ...
2025-06-20
PROVIDENCE, R.I. [Brown University] — Climbing the social ladder isn’t simply a matter of popularity. Rather, people in positions of influence are particularly adept at forming “maps” of their social connections, which they navigate to become prominent in their social network, new research shows.
It’s like having a “social superpower,” according to study author Oriel FeldmanHall, an associate professor of cognitive and psychological sciences at Brown University who is affiliated with the University’s Carney Institute for Brain Science.
“People vary ...
LAST 30 PRESS RELEASES:
[Press-News.org] New way to find “aged” cells marks fresh approach for research into ageing
Electric fields help differentiate healthy and “senescent” cells